DOBUTAMINE ANTAGONIZES EPINEPHRINES BIOCHEMICAL AND CARDIOTONIC EFFECTS - RESULTS OF AN IN-VITRO MODEL USING HUMAN-LYMPHOCYTES AND A CLINICAL-STUDY IN PATIENTS RECOVERING FROM CARDIAC-SURGERY
Rc. Prielipp et al., DOBUTAMINE ANTAGONIZES EPINEPHRINES BIOCHEMICAL AND CARDIOTONIC EFFECTS - RESULTS OF AN IN-VITRO MODEL USING HUMAN-LYMPHOCYTES AND A CLINICAL-STUDY IN PATIENTS RECOVERING FROM CARDIAC-SURGERY, Anesthesiology, 89(1), 1998, pp. 49-57
Background Patients may receive more than one positive inotropic drug
to improve myocardial function and cardiac output, with the assumption
that the effects of two drugs are additive. The authors hypothesized
that combinations of dobutamine and epinephrine would produce additive
biochemical and hemodynamic effects. Methods: The study was performed
in two parts. Phase 1 used human lymphocytes in an in vitro model of
cyclic adenosine monophosphate (cAMP) generation in response to dobuta
mine (10(-8) to 10(-4) M) or epinephrine (10(-9) M to 10(-5) M), and d
obutamine and epinephrine together, Phase 2 was a clinical study in pa
tients after aortocoronary artery bypass in which isobolographic analy
sis compared the cardiotonic effects of dobutamine (1.25, 2.5, or 5 mu
g.kg(-1).min(-1)) or epinephrine (10, 20, or 40 ng.kg(-1).min(-l)), a
lone or in combination. Results: In phase 1, dobutamine increased cAMP
production 41%, whereas epinephrine increased cAMP concentration appr
oximate to 200%. However, when epinephrine (10(-6) IM) and dobutamine
were combined, dobutamine reduced cAMP production at concentrations be
tween 10(-6) to 10(-4) hr (P = 0.001), In patients, 1.25 to 5 mu g.kg(
-1).min(-1) dobutamine increased the cardiac index (CI) 15-28%. Epinep
hrine also increased the CI with each increase in dose. However, combi
ning epinephrine with the two larger doses of dobutamine (2.5 and 5 mu
g.kg(-1).min(-1)) did not increase the CI beyond that achieved with e
pinephrine and the lowest dose of dobutamine (1.25 mu g.kg(-1).min(-1)
). In addition, the isobolographic analysis for equieffective concentr
ations of dobutamine and epinephrine suggests subadditive effects. Con
clusions: Dobutamine inhibits epinephrine-induced production of cAMP i
n human lymphocytes and appears to be subadditive by clinical and isob
olographic analyses of the cardiotonic effects. These findings suggest
that combinations of dobutamine and epinephrine may be less than addi
tive.